GlassScriptPhysician profile
Phillip A Scotti
NPI 1932352242
$21,989.97
in general payments reported to CMS, 2019-2025
20 companies · $1,384 in 2025
The $1,384 reported for 2025 was more than what 86% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $8,103 · 2022: $5,362 · 2023: $5,357 · 2024: $1,784 · 2025: $1,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,725 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,750 · Education: $49.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,725.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,750.00 |
| Education | $49.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15,256.18 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $1,922.25 | 2022-2025 | Emblem Mri S-Icd, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $1,672.82 | 2021-2025 | Linq II, Micra, Selectsecure |
| Abbott Laboratories | $1,492.63 | 2022-2025 | Aveir, Ensite Precision, Gallant |
| Pfizer INC. | $346.82 | 2021-2024 | |
| Amgen INC. | $167.77 | 2021-2023 | Repatha |
| Sanofi-Aventis U.S. LLC | $163.59 | 2021-2022 | |
| Cardiva Medical, INC. | $160.69 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Janssen Pharmaceuticals, INC | $160.33 | 2021-2023 | Xarelto |
| Esperion Therapeutics, INC. | $149.68 | 2021 | |
| Shockwave Medical, INC | $113.56 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $83.36 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $61.35 | 2022-2024 | Camzyos |
| Biotronik INC. | $55.05 | 2025 | Acticor 7 Vr-T Dx |
| Kestra Medical Technology Services, INC. | $49.74 | 2024 | Assure Wcd |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $45.92 | 2025 | Mynx Control Venous |
| Novartis Pharmaceuticals Corporation | $30.72 | 2023 | |
| Becton, Dickinson and Company | $21.00 | 2024 | Arista Ah Flexitip |
| Atricure, INC. | $19.26 | 2024 | |
| Itamar Medical INC | $17.25 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Scotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.